$OCSL Cashflow Statement | Understand Stock

$OCSL

$11.51 +$0.07 (0.61%) Close

$OCSL Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated Statement of Cash Flows

In millions of USD, except per-share amounts

	FY2025 12 months to Sep 30, 2025	FY2024 12 months to Sep 30, 2024	FY2023 12 months to Sep 30, 2023
Operating activities:
Net increase (decrease) in net assets resulting from operations
Adjustments to reconcile net increase (decrease) in net assets resulting from operations to net cash provided by (used in) operating activities:
Net unrealized (appreciation) depreciation
Net realized (gains) losses
PIK interest income
Accretion of original issue discount on investments
Accretion of original issue discount on unsecured notes payable
Amortization of deferred financing costs
Deferred taxes
Purchases of investments
Proceeds from the sales and repayments of investments
Cash received in the OSI2 Merger
Changes in operating assets and liabilities:
(Increase) decrease in interest, dividends and fees receivable
(Increase) decrease in due from portfolio companies
(Increase) decrease in receivables from unsettled transactions
(Increase) decrease in due from broker
(Increase) decrease in other assets
Increase (decrease) in accounts payable, accrued expenses and other liabilities
Increase (decrease) in base management fee and incentive fee payable
Increase (decrease) in due to affiliate
Increase (decrease) in interest payable
Increase (decrease) in payables from unsettled transactions
Increase (decrease) in director fees payable
Net cash provided by (used in) operating activities
Financing activities:
Distributions paid in cash
Borrowings under credit facilities
Repayments of borrowings under credit facilities
Repayments of unsecured notes
Issuance of unsecured notes
Repayments of secured borrowings
Shares issued under the "at the market" offering
Repurchases of common stock under dividend reinvestment plan
Shares issued in private placement
Deferred financing costs paid
Deferred offering costs paid
Net cash provided by (used in) financing activities
Effect of exchange rate changes on foreign currency
Net increase (decrease) in cash and cash equivalents and restricted cash
Cash and cash equivalents and restricted cash, beginning of period
Cash and cash equivalents and restricted cash, end of period
Supplemental information:
Cash paid for interest
Non-cash financing activities:
Issuance of shares of common stock under dividend reinvestment plan
Deferred financing costs
Deferred offering costs
Issuance of shares in connection with the OSI2 Merger
Reconciliation to the Consolidated Statements of Assets and Liabilities
Cash and cash equivalents
Restricted cash
Total cash and cash equivalents and restricted cash

Comments